San Francisco, 15 November 2024: The Report Electroretinogram Market Size, Share & Trends Analysis Report By Type (Full-field flash ERG, Pattern ERG, Multifocal ERG), By Product (Handheld, Tabletop), By Application (Clinical Diagnostic, Research), By Region, And Segment Forecasts, 2030 - 2030

The global electroretinogram market size is estimated to reach USD 1.15 billion by 2030, expanding at a CAGR of 8.9% from 2030 to 2030, according to a new report by Grand View Research, Inc. The rising demand for early disease diagnosis, constant innovations & development of newer technologies, and the growing geriatric population, which is at risk of developing eye disorders like glaucoma and diabetic retinopathy, are expected to drive the market growth. The eyes being the most sensitive part of the body, ophthalmic procedures are conducted with high accuracy and precision levels. This is the main driving factor for the growth of the market. Moreover, increasing disposable income levels, rising awareness about early disease diagnosis, and increased government funds for ophthalmological R&D are supporting the market growth.

Electroretinogram is also used for evaluating the efficiency of eye safety procedures. The market exhibited marginally positive growth during and after the COVID-19 pandemic. According to the study published on PubMed Central by NCBI, COVID-19 can affect the retinal level, such as affecting retinal vasculature. Moreover, few cases related to retinal side effects were reported after the COVID-19 vaccination. Hence, to diagnose and monitor the health of the retina and other related eye disorders, electroretinograms were used, thereby supporting market growth. However, the high cost of electroretinography procedures and risks associated with the device is expected to hamper the market growth in the coming years.

Ongoing innovation and the increasing number of ophthalmology clinics and research centers are driving the demand for electroretinograms in the market. Additionally, the growing prevalence of eye disorders, including diabetic retinopathy, glaucoma, retinitis pigmentosa, macular degeneration, and cone-rod dystrophy, is anticipated to boost market growth in the forecast period. Factors such as a preference for early disease diagnosis, heightened screen time during the pandemic, and a rapidly aging population are also expected to contribute to market expansion.

The electroretinogram (ERG) is a clinical ophthalmic diagnostic test that measures the electrical activity of the retina in response to a light stimulus. The electroretinogram ascends from currents generated directly by retinal neurons in combination with contributions from retinal glia. Ophthalmologists use these electroretinograms to determine the need for retinal surgery or other eye surgeries such as cataract surgery. It is used to diagnose patients with several symptoms, such as photophobia, nyctalopia, reduced visual acuity, and field defects.

Request sample report of Electroretinogram Market@ https://www.grandviewresearch.com/industry-analysis/electroretinogram-market-report/request/rs1

The rising prevalence of diabetic retinopathy is anticipated to significantly drive market growth in the coming years. A recent study published by the CDC highlights that diabetes is a leading cause of new blindness cases among adults, with diabetic retinopathy affecting nearly one-third of adults with diabetes aged 40 and older. In 2021, it was estimated that approximately 9.6 million individuals in the United States were living with diabetic retinopathy (DR), of which around 1.84 million experienced vision-threatening forms of the condition. The prevalence of DR varies significantly across age groups, with the lowest rate of 13.0% observed in individuals younger than 25, while the highest rate of 28.4% was found among those aged 65 to 79.

Electroretinogram Market Report Highlights

• The full-field flash ERG (ffERG) segment accounted for the largest revenue share in 2024 followed by the Multifocal ERG (mfERG)
• The tabletop devices segment held the largest market share in 2024 owing to the easy availability of a wide range of such devices and constant product developments catering to the market demands
• Clinical diagnostic is dominating the market owing to the increasing prevalence of chronic disorders, such as glaucoma & diabetic retinopathy, and the growing need for early disease diagnosis
• North America held the largest market share in 2024 and is expected to maintain its dominance over the forecast period

Electroretinograms are crucial in diagnosing various inherited and acquired retinal disorders, further underscoring their importance in the ophthalmology market. Conditions such as retinitis pigmentosa, which leads to a gradual loss of peripheral and night vision, and retinoblastoma, a type of retinal cancer, can be effectively assessed using this technology. Additionally, electroretinograms are valuable in diagnosing macular degeneration, characterized by the deterioration of macular cells and resulting vision loss, as well as retinal detachment and cone-rod dystrophy, which involves the weakening of cone and rod cells. The growing recognition of these disorders and the utility of electroretinograms in their diagnosis will likely contribute to increased demand in the market.

The electroretinogram industry is characterized by moderate concentration, with several key players leading the market. Established manufacturers dominate through technological advancements and extensive distribution networks while emerging companies focus on niche products and innovative solutions. The industry encompasses a range of devices designed for diagnosing retinal disorders, emphasizing precision and reliability. Regulatory compliance is crucial, influencing product development and market entry. Additionally, the increasing prevalence of eye disorders and a growing emphasis on early diagnosis drive competitive dynamics, prompting ongoing innovation and collaboration among stakeholders to enhance diagnostic capabilities and improve patient outcomes.

Electroretinogram Market Report Scope

The industry exhibits a high degree of innovation, driven by advancements in technology and a growing understanding of retinal diseases. Innovations include the development of portable and compact electroretinogram devices, enhancing accessibility and ease of use in various clinical settings. Enhanced imaging techniques and digital signal processing have improved the accuracy and reliability of test results. Furthermore, ongoing research into new diagnostic algorithms and the integration of artificial intelligence are paving the way for more precise assessments of retinal function. This focus on innovation is essential for addressing the rising demand for effective diagnostics in retinal disorders.